Gabriella Beni joins Eevia Health Plc as the new Chief Financial Officer
Eevia Health Plc ("Eevia" or "The Company") is welcoming Gabriella Beni as our new Chief Financial Officer. Kim Nurmi-Aro will leave the Company on March 16th and the Company wishes him the very best in his new professional endeavors close to his home in the city of Vaasa. Gabriella Beni will take over the position on March 17th.
Gabriella Beni comes from the position of Chief Accountant and Deputy Chief Financial Officer at the Central European University, where she supervised a team of twelve finance professionals. Gabriella Beni is an IRFS Chartered accountant with an M.Sc. in Economic and Social sciences. The Central European University is an academic institution founded in 1991 in Hungary by the investor and philanthropist George Soros. Over the last 23 years, since 1997, Gabriella Beni has followed the growth of the University in various financial positions, including the current one since 2006.
Gabriella Beni is from Hungary, now living in Seinäjoki, Finland, working remotely over the last two years with the University. Besides her strong professional credentials, Gabriella's mother tongue is Hungarian, which will be of significant value to Eevia, as Hungary is the main origin of elderberry raw material.
"We are delighted to welcome Gabriella Beni to our team. Gabriella is superbly structured, analytical, and competent in financial management, system integration, and business control. She will help us in developing a robust business management system. Her broad understanding of business processes, as well as strong leadership experience, combined with her accounting competence both in financial and management accounting, will help us develop product profitability management and solid corporate governance." comments Stein Ulve, CEO Eevia Health Plc.
Seinäjoki, Finland 15.3.2022
For further information, please contact:
Stein Ulve, CEO, Eevia Health Plc
Email: [email protected]
Telephone: +358 400 22 5967
Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients to dietary supplements and food brands globally. These global brands utilize the ingredients in their consumer product formulas.
Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product; Elderberry extract, is made from cultivated berries, most of Eevia's other raw materials, such as bilberry, lingonberry, Chaga-mushroom, and pine bark, are wild-harvested in a sustainable fashion.
Eevia Health operates a modern green-chemistry production facility in Finland. The factory operates near the raw material harvest areas. A uniquely short value chain enables an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. Eevia listed its shares at Spotlight Stock Market in Sweden in June 2021, with the short name EEVIA.
To learn more, please visit www.eeviahealth.com or follow Eevia Health on LinkedIn @EeviaHealth.
Om Eevia Health
Eevia Health targets health problems with bioactive extracts from plant material. The human body has an incredible ability to restore good health. However, sometimes the body needs active support. Our mission is to support good health and well-being with plant extracts which have scientifically documented health benefits. Eevia Health manufactures and markets organic ingredients from abundant plant material in the Arctic. Our products are targeted against low-grade inflammation, problems in eye and brain health, and metabolic effects. We collaborate with scientists in Finland and abroad to scientifically substantiate the positive effects of ingredients and also to document the safety of use.